NCT04975308 2025-07-11EMBER-3Eli Lilly and CompanyPhase 3 Active not recruiting874 enrolled 29 charts 1 FDA
NCT05509790 2025-04-18A Study of LY3484356 in Chinese Participants With Advanced Breast CancerEli Lilly and CompanyPhase 1 Active not recruiting17 enrolled